000 01198 a2200349 4500
005 20250513202334.0
264 0 _c19991223
008 199912s 0 0 eng d
022 _a0193-841X
024 7 _a10.1177/0193841X9902300603
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFreedman, D A
245 0 0 _aThe swine flu vaccine and Guillain-Barré syndrome. A case study in relative risk and specific causation.
_h[electronic resource]
260 _bEvaluation review
_cDec 1999
300 _a619-47 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCausality
650 0 4 _aGuillain-Barre Syndrome
_xepidemiology
650 0 4 _aHumans
650 0 4 _aImmunization Programs
_xlegislation & jurisprudence
650 0 4 _aInfluenza A virus
650 0 4 _aInfluenza Vaccines
_xadverse effects
650 0 4 _aLiability, Legal
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aModels, Statistical
650 0 4 _aRisk
650 0 4 _aUnited States
_xepidemiology
700 1 _aStark, P B
773 0 _tEvaluation review
_gvol. 23
_gno. 6
_gp. 619-47
856 4 0 _uhttps://doi.org/10.1177/0193841X9902300603
_zAvailable from publisher's website
999 _c10616980
_d10616980